4.7 Article

Subthreshold Posttraumatic Stress Disorder in the World Health Organization World Mental Health Surveys

Journal

BIOLOGICAL PSYCHIATRY
Volume 77, Issue 4, Pages 375-384

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2014.03.028

Keywords

Epidemiology; Nosology; Partial PTSD; Posttraumatic stress disorder; PTSD; Subthreshold PTSD

Funding

  1. National Institute of Mental Health [R01 MH070884, R01 MH093612-01, U01-MH60220]
  2. John D. and Catherine T. MacArthur Foundation
  3. Pfizer Foundation
  4. United States Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]
  5. Fogarty International Center [FIRCA R03-TW006481]
  6. Pan American Health Organization
  7. Eli Lilly and Company
  8. Ortho-McNeil Pharmaceutical
  9. GlaxoSmithKline
  10. Bristol-Myers Squibb
  11. State of Sao Paulo Research Foundation Thematic Project [03/00204-3]
  12. Ministry of Social Protection
  13. Ministry of Health
  14. National Center for Public Health Protection
  15. European Commission [QLG5-1999-01042, 2004123, 20081308]
  16. Piedmont Region, Italy
  17. Fondo de Investigacion Sanitaria
  18. Instituto de Salud Carlos III, Spain [00/0028]
  19. Ministerio de Ciencia y Tecnologia, Spain [SAF 2000-158-CE]
  20. Departament de Salut, Generalitat de Catalunya, Spain
  21. Instituto de Salud Carlos III [CB06/02/0046, RD06/0011 REM-TAP]
  22. Grant for Research on Psychiatric and Neurological Diseases and Mental Health [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]
  23. Japan Ministry of Health, Labour and Welfare
  24. National Institute of Psychiatry Ramon de la Fuente [INPRFMDIES 4280]
  25. National Council on Science and Technology [CONACyT-G30544-H]
  26. PanAmerican Health Organization
  27. New Zealand Ministry of Health, Alcohol Advisory Council
  28. Health Research Council
  29. Ministry of Public Health (former Ministry of Health)
  30. Substance Abuse and Mental Health Services Administration
  31. Robert Wood Johnson Foundation [044708]
  32. John W. Alden Trust
  33. Abbott Laboratories
  34. AstraZeneca
  35. Jazz Pharmaceuticals
  36. Johnson Johnson
  37. Lundbeck
  38. Orion
  39. Pfizer
  40. Pharmacia
  41. Roche
  42. Servier
  43. Solvay
  44. Sumitomo
  45. Takeda
  46. Tikvah
  47. Wyeth
  48. Analysis Group
  49. EPIQ
  50. Johnson & Johnson Pharmaceuticals
  51. Ortho-McNeil Janssen Scientific Affairs
  52. Sanofi-Aventis Groupe
  53. Shire
  54. Walgreens
  55. DataStat, Inc
  56. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [03/00204-3] Funding Source: FAPESP

Ask authors/readers for more resources

BACKGROUND: Although only a few people exposed to a traumatic event (TE) develop posttraumatic stress disorder (PTSD), symptoms that do not meet full PTSD criteria are common and often clinically significant. Individuals with these symptoms sometimes have been characterized as having subthreshold PTSD, but no consensus exists on the optimal definition of this term. Data from a large cross-national epidemiologic survey are used in this study to provide a principled basis for such a definition. METHODS: The World Health Organization World Mental Health Surveys administered fully structured psychiatric diagnostic interviews to community samples in 13 countries containing assessments of PTSD associated with randomly selected TEs. Focusing on the 23,936 respondents reporting lifetime TE exposure, associations of approximated DSM-5 PTSD symptom profiles with six outcomes (distress-impairment, suicidality, comorbid feardistress disorders, PTSD symptom duration) were examined to investigate implications of different subthreshold definitions. RESULTS: Although consistently highest outcomes for distress-impairment, suicidality, comorbidity, and PTSD symptom duration were observed among the 3.0% of respondents with DSM-5 PTSD rather than other symptom profiles, the additional 3.6% of respondents meeting two or three of DSM-5 criteria B-E also had significantly elevated scores for most outcomes. The proportion of cases with threshold versus subthreshold PTSD varied depending on TE type, with threshold PTSD more common following interpersonal violence and subthreshold PTSD more common following events happening to loved ones. CONCLUSIONS: Subthreshold DSM-5 PTSD is most usefully defined as meeting two or three of DSM-5 criteria B-E. Use of a consistent definition is critical to advance understanding of the prevalence, predictors, and clinical significance of subthreshold PTSD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available